Indoco Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indoco Remedies has informed the stock exchanges that its trading window will remain closed from Tuesday, July 1, 2025, until 48 hours after the declaration of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26). During this period, all designated persons of the company and their immediate relatives are prohibited from trading in the company's equity shares, as required under SEBI's Prohibition of Insider Trading Regulations, 2015. The exact date of the board meeting to approve these Q1 results will be communicated later. This is a routine compliance filing typically done ahead of quarterly results.
This is a standard regulatory disclosure with no direct impact on shareholders or stock price. However, it signals that the company's Q1 FY26 earnings announcement is expected within the next few weeks, which investors should watch for as it will be the next potential stock-moving catalyst.